Company intelligence / Profile preview

DiNovA Medtech

Hangzhou, Zhejiang, China

Ownership: Private
Development stage: Other

Overview

DiNovA Medtech operates as a specialized medical device incubator and innovation hub, investing in and operating portfolio companies that have reached or are progressing toward commercialization in structural heart, cardiac electrophysiology, pulmonary disease and diabetes management, including continuous glucose monitoring systems.[1][2]

Therapeutic areas: EndocrinologyCardiovascularPulmonology
Modalities: DeviceNon-pharmacological therapy
Industry: Therapeutic Medical Devices

Partnerships

Metronom Health (joint venture in China for continuous glucose monitoring system development, manufacturing and commercialization)[2]Ascendum Capital (healthcare-focused investment platform partnering with DiNovA and Metronom in the CGM joint venture)[2]

Beyond the preview

Go deeper on DiNovA Medtech.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on DiNovA Medtech.

Explore the full profile